De Novo Pyrimidine Synthesis Is a Collateral Metabolic Vulnerability in NF2-deficient Mesothelioma
Ontology highlight
ABSTRACT: De Novo Pyrimidine Synthesis Is a Collateral Metabolic Vulnerability in NF2-deficient Mesothelioma
PROVIDER: PRJNA1255527 | ENA |
REPOSITORIES: ENA
ACCESS DATA